Study of the Families Moving Forward Website Behavioral Intervention for Teachers of Students With Fetal Alcohol Spectrum Disorder
CompletedNAResults postedLast updated 29 January 2025
What this trial tests
NA trial testing Families Moving Forward (FMF) Teacher adapted training in Fetal Alcohol Spectrum Disorders in 37 participants. Completed in 29 January 2024.
Timeline
24 August 2023
Primary endpoint 29 January 2024
29 January 2024
Quick facts
Lead sponsor
University of Rochester
Phase
NA
Status
Completed
Study type
INTERVENTIONAL
Allocation
randomized
Design
parallel
Masking
none
Primary purpose
treatment
Enrollment
37
Start date
24 August 2023
Primary completion
29 January 2024
Estimated completion
29 January 2024
Sites
1 location across United States
Drugs / interventions tested
Families Moving Forward (FMF) Teacher adapted training
18 and older, any sex, with Fetal Alcohol Spectrum Disorders. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Change in Mean Knowledge About FASD From Baseline to 6 WeeksPrimary· baseline to 6 weeks
Teacher FASD knowledge will be measured using the "Fetal Alcohol Spectrum Disorder (FASD) Knowledge" survey. The survey scores range from 0-33 with higher scores indicating more knowledge about FASD.
Baseline
Group
Value
95% CI
Website Treatment
15.50
± 2.53
Delayed Treatment Control
17.14
± 2.45
6 weeks
Group
Value
95% CI
Website Treatment
16.57
± 3.54
Delayed Treatment Control
17.14
± 1.94
Change in Personal Efficacy Mean From Baseline to 6 WeeksPrimary· baseline to 6 weeks
Personal efficacy will be measured by the Personal Efficacy subscale of the Teaching Self-Efficacy Scale. This subscale has 5 items and ranges from 5-30, with higher scores indicating higher perceived personal efficacy.
baseline
Group
Value
95% CI
Website Treatment
23.36
± 3.29
Delayed Treatment Control
23.25
± 2.53
6 weeks
Group
Value
95% CI
Website Treatment
23.54
± 3.24
Delayed Treatment Control
23.08
± 2.15
Change in Teaching Efficacy Means From Baseline to 6 WeeksPrimary· baseline to 6 weeks
Teaching efficacy will be measured by the Teaching Efficacy subscale of the Teaching Self-Efficacy Scale. This subscale has 5 items and ranges from 5-30, with higher scores indicating higher perceived teaching efficacy.
baseline
Group
Value
95% CI
Website Treatment
22.27
± 3.13
Delayed Treatment Control
22.67
± 5.48
6 weeks
Group
Value
95% CI
Website Treatment
21.83
± 3.92
Delayed Treatment Control
22.42
± 5.38
Mean Difference in Sensory Seeking Attributions at 6 WeeksPrimary· 6 weeks
Sensory seeking attributions will be measured using the "Reasons for Children's Behavior" survey. This subscale has 5 items and scores range from 5-30, with higher scores representing higher endorsement of sensory seeking attributions.
Group
Value
95% CI
Website Treatment
16.38
± 5.84
Delayed Treatment Control
14.00
± 4.81
Mean Difference in Sensory Avoiding Attributions at 6 WeeksPrimary· 6 weeks
Sensory avoiding attributions will be measured using the "Reasons for Children's Behavior" survey. This subscale has 5 items and scores range from 5-30, with higher scores representing higher endorsement of sensory avoiding attributions.
Group
Value
95% CI
Website Treatment
19.36
± 6.02
Delayed Treatment Control
15.85
± 7.39
Mean Difference in Task - Willful Attributions at 6 WeeksPrimary· 6 weeks
Task - willful attributions will be measured using the "Reasons for Children's Behavior" survey. This subscale has 3 items and scores range from 3-18, with higher scores representing higher endorsement of task - willful attributions.
Group
Value
95% CI
Website Treatment
7.43
± 2.87
Delayed Treatment Control
7.08
± 2.94
Mean Difference in Task - Ability Attributions at 6 WeeksPrimary· 6 weeks
Task - ability attributions will be measured using the "Reasons for Children's Behavior" survey. This subscale has 5 items and scores range from 5-30, with higher scores representing higher endorsement of task - ability attributions.
Group
Value
95% CI
Website Treatment
20.71
± 3.60
Delayed Treatment Control
17.62
± 4.54
Mean Difference in Disruptive Behavior Attributions at 6 WeeksPrimary· 6 weeks
Disruptive behavior attributions will be measured using the "Reasons for Children's Behavior" survey. This subscale has 5 items and scores range from 5-30, with higher scores representing higher endorsement of disruptive behavior attributions.
Group
Value
95% CI
Website Treatment
12.08
± 5.19
Delayed Treatment Control
10.85
± 6.77
Mean Difference in Emotional Support Attributions at 6 WeeksPrimary· 6 weeks
Emotional support seeking attributions will be measured using the "Reasons for Children's Behavior" survey. This subscale has 4 items and scores range from 4-24, with higher scores representing higher endorsement of emotional support seeking attributions.
Group
Value
95% CI
Website Treatment
18.71
± 3.75
Delayed Treatment Control
17.92
± 4.86
Mean Difference in Dysregulated Behavior Attributions at 6 WeeksPrimary· 6 weeks
Dysregulated behavior attributions will be measured using the "Reasons for Children's Behavior" survey. This subscale has 3 items and scores range from 3-18, with higher scores representing higher endorsement of dysregulated behavior attributions.
Group
Value
95% CI
Website Treatment
10.31
± 3.45
Delayed Treatment Control
7.77
± 3.61
Mean Overall Quality of Website (Website Group Only)Primary· 6 weeks
Overall quality will be measured using the Mobile Application Rating Scale - user version. Overall quality is a sum of the Engagement, Functionality, Aesthetics, and Information subscales. Each subscale represents a mean of items and ranges from 1 to 6. The overall total quality score is a sum of these scales and ranges from 4 to 24, with higher scores indicating higher overall quality.
Group
Value
95% CI
Website Treatment
16.88
± 2.00
Mean Subjective Quality of Website (Website Group Only)Primary· 6 weeks
Subjective quality will be measured using the Subjective Quality subscale of the Mobile Application Rating Scale - user version. This subscale has 4 items in total. Each item is rated on a scale from 1 to 6 and the total score represents a mean across items, with higher scores indicating higher subjective quality.
Group
Value
95% CI
Website Treatment
3.70
± 0.72
Sponsor's own description
The purpose of this study is to find out if the FMF Connect Teacher Companion website is acceptable and usable by teachers. The FMF Connect Teacher Companion website is a website for teachers adapted from the Families Moving Forward (FMF) Program. The FMF Program is an evidence-based intervention for caregivers of children with FASD. The study will determine if the a web page intervention is feasible and acceptable by looking at enrollment and retention of study subjects and acceptability of assessments.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
Other recruiting trials for Fetal Alcohol Spectrum Disorders
Currently open trials in the same condition.
NCT06847165 — Trigeminal Nerve Stimulation for Children With Prenatal Alcohol Exposure
· NA
· recruiting
NCT06638463 — My Health Coach App RCT
· NA
· recruiting
NCT05960461 — Families Moving Forward (FMF) Connect Pro for Mental Health Providers
· NA
· recruiting
NCT04395196 — RCT of Prenatal Choline Supplementation During Pregnancy to Mitigate Adverse Effects of Prenatal Alcohol Exposure
· Phase 2
· recruiting
NCT05534568 — The Oklahoma Parent-Child Assistance Program
· NA
· recruiting
Other University of Rochester trials
Trials by the same sponsor.
NCT07075965 — Calcium Channel Blocker in Myotonic Dystrophy Type 1
· Phase 1
· not yet recruiting
NCT07423104 — A Study of Cladribine, Low Dose Cytarabine, and Venetoclax in Treatment of Relapsed/Refractory or Secondary Acute Myeloi
· Phase 2
· not yet recruiting
NCT05744869 — SBAT for Health Equity
· NA
· not yet recruiting
NCT06052956 — Efficacy of Methylene Blue Photodynamic Therapy for Treatment of Deep Tissue Abscesses
· Phase 2
· not yet recruiting
NCT07032636 — Reducing Crises and Suicide Within the Idaho Army National Guard
· NA
· not yet recruiting
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Rochester
Last refreshed: 29 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05986565.